SPR-00305(1965261-97-5)
- Name: SPR-00305
- Synonyms:SPR-00305 POTENTLY INHIBITED THE MVFR PATHWAY WITH IC50S OF 115 NM AGAINST 4-HYDROXY-2-HEPTYLQUINOLINE (HHQ); 93 NM AGAINST PYOCYANIN (PYO) AND 109 NM AGAINST 3;4-DIHYDROXY-2-HEPTOQUINOLINE (PQS) IN PA14.;4-dihydroxy-2-heptoquinoline (PQS) in PA14.;93 nM against pyocyanin (PYO) and 109 nM against 3;SPR-00305 potently inhibited the MvfR pathway with IC50s of 115 nM against 4-hydroxy-2-heptylquinoline (HHQ);2-Naphthalenecarboxamide, 7-chloro-3-[2-(6-cyclopropyl-1H-indol-3-yl)-2-oxoethoxy]-;SPR-00305;7-Chloro-3-[2-(6-cyclopropyl-1H-indol-3-yl)-2-oxoethoxy]naphthalene-2-carboxamide
- Molecular Formula:C24H19ClN2O3
- Molecular Weight:418.87
- CAS Registry Number:1965261-97-5
- EINECS:
- Melting Point:728.1±60.0 °C(Predicted)
- Water Solubility:
Other Product
- 1964490-63-8/1,7-Naphthyridine-6-carboxylic acid, 5,6,7,8-tetrahydro-
- 1964503-38-5/Azido-PEG3-phosphonic acid
- 1964503-39-6/Carboxy-PEG4-phosphonic acid ethyl ester
- 1964506-29-3/ODN 20844
- 1964516-64-0/4-Thiazolecarboxylic acid, 2-[4-[[4-(aminosulfonyl)-3-fluorophenyl]methyl]-5-(cyclopropylmethyl)-3-[4-fluoro-3-[2-(5-methyl-2-thienyl)ethynyl]phenyl]-1H-pyrazol-1-yl]-
- 1964517-04-1/4-Thiazolecarboxylic acid, 2-[4-[[4-(aminosulfonyl)-3-fluorophenyl]methyl]-5-(cyclopropylmethyl)-3-[3-[2-(5-methyl-2-thienyl)ethynyl]phenyl]-1H-pyrazol-1-yl]-
- 1964517-61-0/Thieno[3,2-d]pyrimidin-4-amine, 7-bromo-N-(1,1-dimethylethyl)-
- 1964517-87-0/1-(1H-Benzotriazol-1-yl)-2-cyclopropylethanone
- 196493-51-3/Titanium, dichloro[(dimethylsilylene)bis[(1,2,3,3a,7a-η)-1H-inden-1-ylidene]]-
- 196493-76-2/2,3-dinor Thromboxane B1
- 196494-59-4/2,5-Pyrrolidinedimethanol, 3,4-dihydroxy-, (2S,3S,4S,5R)-
- 196521-36-5/5-(hydroxymethyl)-8-methyl-3-(phenylsulfonyl)-2H-pyrano[2,3-c]pyridin-2-one
- 196522-49-3/NA
- 1965238-69-0/2-Imidazolidinone, 4-(1-methylethyl)-1-[(1S)-1-phenylethyl]-, (4R)-
- 1965248-01-4/Piperazine, 1-cyclobutyl-4-[4,5-dihydro-1-[[4-(3-thienyl)phenyl]sulfonyl]-1H-imidazol-2-yl]-
- 1965249-98-2/1H-Pyrazolo[4,3-c]pyridine, 4,5,6,7-tetrahydro-1-methyl-, 2,2,2-trifluoroacetate (1:1)
- 1965250-77-4/2-Thiopheneacetonitrile, 5-(trimethylstannyl)-α-[[5-(trimethylstannyl)-2-thienyl]methylene]-
- 1965253-60-4/Ethanol, 2,2'-[(1-methylethylidene)bis(thio)]bis-
- 1965260-57-4/7-chloro-3-methoxyquinoline
- 1965261-97-5/SPR-00305
- 1965266-29-8/ethyl (4R)-4-{[(tert-butoxy)carbonyl]amino}-3-hydroxypentanoate
- 1965290-13-4/rac-(1S,6R)-3,9-diazabicyclo[4.2.1]nonan-4-one dihydrochloride
- 1965291-08-0/Ibrexafungerp citrate
- 1965304-61-3/tert-butyl [2-(4-amino-1H-pyrazol-1-yl)ethyl]carbamate oxalate
- 1965304-63-5/4-Methyl-5-trifluoromethyl-2-(4-trifluoromethyl-phenyl)-thiazole
- 1965304-67-9/methyl 3-aminobicyclo[2.2.1]hept-5-ene-2-carboxylate hydrochloride
- 1965304-68-0/2-Fluoro-1-nitro-3,5-bis(trifluoromethyl)benzene
- 1965304-69-1/7-Amino-5-phenylpyrazolo[1,5-a]pyrimidine-3-thiocarboxamide
- 1965304-72-6/5-Thiazolecarboxylic acid, 2-(2-methylphenyl)-4-phenyl-, ethyl ester
- 1965304-73-7/2-(2-pyridin-2-yl-1,3-thiazol-4-yl)phenol